Impact of prehabilitation during neoadjuvant chemotherapy and interval cytoreductive surgery on ovarian cancer patients : a pilot study
Miralpeix, Ester (Hospital del Mar (Barcelona, Catalunya))
Sole-Sedeno, Josep-Maria (Hospital del Mar (Barcelona, Catalunya))
Rodriguez-Cosmen, Cristina (Hospital del Mar (Barcelona, Catalunya))
Taus, Alvaro (Institut Hospital del Mar d'Investigacions Mèdiques)
Muns, Maria-Dolors (Hospital del Mar (Barcelona, Catalunya))
Fabregó, Berta (Hospital del Mar (Barcelona, Catalunya))
Mancebo, Gemma (Hospital del Mar (Barcelona, Catalunya))
Universitat Autònoma de Barcelona

Date:	2022
Abstract:	Cytoreductive surgery followed by systemic chemotherapy is the standard of treatment in advanced ovarian cancer where feasible. Neoadjuvant chemotherapy (NACT) followed by surgery is applicable where upfront cytoreductive surgery is not feasible because of few certain reasons. Nevertheless, surgical interventions and the chemotherapy itself may be associated with postoperative complications usually entailing slow postoperative recovery. Prehabilitation programs consist of the patient's preparation before surgery to improve the patient's functional capacity. The aim of this study was to evaluate the impact of a prehabilitation program during neoadjuvant treatment and interval cytoreductive surgery for ovarian cancer patients. A retrospective observational pilot study of patients with advanced ovarian cancer treated with NACT and interval cytoreductive surgery was conducted. The prehabilitation group received a structured intervention based on physical exercise, nutritional counseling, and psychological support. Nutritional parameters were assessed preoperatively and postoperatively, and functional parameters and perioperative and postoperative complications were also recorded. A total of 29 patients were included in the study: 14 in the prehabilitation group and 15 in the control group. The patients in the prehabilitation program showed higher mean total protein levels in both preoperative (7. 4 vs. 6. 8, p = 0. 004) and postoperative (4. 9 vs. 4. 3, p = 0. 005) assessments. Up to 40% of controls showed intraoperative complications vs. 14. 3% of patients in the prehabilitation group, and the requirement of intraoperative blood transfusion was significantly lower in the prehabilitation group (14. 3% vs. 53. 3%, p = 0. 027). The day of the first ambulation, rate of postoperative complications, and length of hospital stay were similar between the groups. Finally, trends towards shorter time between diagnosis and interval cytoreductive surgery (p = 0. 097) and earlier postoperative diet restart (p = 0. 169) were observed in the prehabilitation group. Prehabilitation during NACT in women with ovarian cancer candidates to interval cytoreductive surgery may improve nutritional parameters and thereby increase postoperative recovery. Nevertheless, the results of this pilot study are preliminary, and further studies are needed to determine the clinical impact of prehabilitation programs.
Rights:	Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, la comunicació pública de l'obra i la creació d'obres derivades, fins i tot amb finalitats comercials, sempre i quan es reconegui l'autoria de l'obra original.
Language:	Anglès
Document:	Article ; recerca ; Versió publicada
Subject:	Prehabilitation ; Neoadjuvant chemotherapy ; Interval cytoreductive surgery ; Ovarian cancer
Published in:	World Journal of Surgical Oncology, Vol. 20 (february 2022) , ISSN 1477-7819

DOI: 10.1186/s12957-022-02517-1
PMID: 35197061

10 p, 970.5 KB

The record appears in these collections:
Articles > Research articles
Articles > Published articles